Danaher Corp. (NYSE:DHR) has received an average recommendation of “Buy” from the twenty-one brokerages that are presently covering the company. Seven equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $92.22.

Several research analysts have weighed in on the stock. Vetr upgraded shares of Danaher Corp. from a “hold” rating to a “buy” rating and set a $81.69 target price on the stock in a research report on Monday, September 12th. Citigroup Inc. restated a “market perform” rating and set a $85.00 target price on shares of Danaher Corp. in a research report on Tuesday, August 2nd. Barclays PLC upped their target price on shares of Danaher Corp. from $90.00 to $91.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 7th. Morgan Stanley restated a “buy” rating and set a $86.00 target price on shares of Danaher Corp. in a research report on Wednesday, August 31st. Finally, Cowen and Company upgraded shares of Danaher Corp. from a “market perform” rating to an “outperform” rating and set a $95.00 target price on the stock in a research report on Friday, November 11th.

Shares of Danaher Corp. (NYSE:DHR) traded up 0.183% during mid-day trading on Tuesday, hitting $79.175. 967,646 shares of the stock were exchanged. The stock has a market cap of $54.77 billion, a PE ratio of 22.147 and a beta of 1.06. The company has a 50-day moving average of $78.41 and a 200 day moving average of $78.26. Danaher Corp. has a one year low of $61.60 and a one year high of $82.64.

Danaher Corp. (NYSE:DHR) last issued its quarterly earnings results on Thursday, October 20th. The company reported $0.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.82 by $0.05. Danaher Corp. had a net margin of 11.78% and a return on equity of 12.90%. The business had revenue of $4.10 billion for the quarter, compared to analyst estimates of $4.14 billion. During the same period in the previous year, the business posted $1.05 earnings per share. The business’s revenue was up 17.6% compared to the same quarter last year. On average, equities analysts predict that Danaher Corp. will post $3.59 earnings per share for the current year.

In related news, insider Thomas Patrick Joyce, Jr. sold 36,125 shares of the company’s stock in a transaction that occurred on Friday, October 21st. The shares were sold at an average price of $79.68, for a total transaction of $2,878,440.00. Following the completion of the transaction, the insider now owns 205,407 shares of the company’s stock, valued at $16,366,829.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 12.60% of the company’s stock.

A number of institutional investors have recently modified their holdings of DHR. Benjamin F. Edwards & Company Inc. raised its position in shares of Danaher Corp. by 115.7% in the third quarter. Benjamin F. Edwards & Company Inc. now owns 1,309 shares of the company’s stock valued at $103,000 after buying an additional 702 shares during the period. Global X Management Co. LLC raised its position in shares of Danaher Corp. by 83.4% in the second quarter. Global X Management Co. LLC now owns 1,080 shares of the company’s stock valued at $109,000 after buying an additional 491 shares during the period. Motco raised its position in shares of Danaher Corp. by 4.4% in the third quarter. Motco now owns 1,655 shares of the company’s stock valued at $129,000 after buying an additional 70 shares during the period. Thompson Davis & CO. Inc. raised its position in shares of Danaher Corp. by 15.3% in the second quarter. Thompson Davis & CO. Inc. now owns 1,284 shares of the company’s stock valued at $130,000 after buying an additional 170 shares during the period. Finally, Cribstone Capital Management LLC bought a new position in shares of Danaher Corp. during the second quarter valued at approximately $132,000. 74.86% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: “Danaher Corp. (DHR) Given Consensus Rating of “Buy” by Brokerages” was first published by Financial Market News and is the sole property of of Financial Market News. If you are viewing this piece of content on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this piece of content can be read at http://www.financial-market-news.com/danaher-corp-dhr-given-consensus-rating-of-buy-by-brokerages/1208763/.

About Danaher Corp.

Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services.

5 Day Chart for NYSE:DHR

Receive News & Ratings for Danaher Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corp. and related companies with MarketBeat.com's FREE daily email newsletter.